{"date":"2026-07-20","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2026-07-20-2013-xrynyc","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-07-20","time":"20:13:03","subject":"代重要子公司Belite Bio, Inc公告受邀參加美國視網膜專家學會2026年會（ASRS 2026）（補充公告）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-07-20 20:13，「代重要子公司Belite Bio, Inc公告受邀參加美國視網膜專家學會2026年會（ASRS 2026）（補充公告）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-07-20-1959-2x7usu","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-07-20","time":"19:59:24","subject":"公告修正本公司114年度股東會年報部份內容(更正事實發生日)","clause":"第44款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-07-20 19:59，「公告修正本公司114年度股東會年報部份內容(更正事實發生日)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-07-20-1946-9rbm9a","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-07-20","time":"19:46:13","subject":"公告修正本公司114年度股東會年報部分內容","clause":"第44款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-07-20 19:46，「公告修正本公司114年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-07-20-1741-1nl9un2","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-07-20","time":"17:41:48","subject":"公告本公司董事會決議增加投資GenEditBio Limited(Cayman)","clause":"第20款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-07-20 17:41，「公告本公司董事會決議增加投資GenEditBio Limited(Cayman)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-07-20-1736-1ijbmw5","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-07-20","time":"17:36:53","subject":"本公司董事會決議除權除息基準日、調整配股配息率暨可轉換公司債停止轉換期間公告","clause":"第14款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-07-20 17:36，「本公司董事會決議除權除息基準日、調整配股配息率暨可轉換公司債停止轉換期間公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-07-20-1644-p67uuk","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-07-20","time":"16:44:55","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-07-20 16:44，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-07-20-1629-nv0s8o","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-07-20","time":"16:29:26","subject":"本公司授權夥伴長春金賽藥業向新加坡健康科學局（Health Science Authority, HSA）提交之前列腺癌新劑型新藥CAMCEVI 42mg藥證申請獲上市許可","clause":"第10款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-07-20 16:29，「本公司授權夥伴長春金賽藥業向新加坡健康科學局（Health Science Authority, HSA）提交之前列腺癌」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-07-20-1625-10p168k","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-07-20","time":"16:25:30","subject":"公告與捷克NCTB簽訂合作意向書","clause":"第8款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-07-20 16:25，「公告與捷克NCTB簽訂合作意向書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-07-20-1618-1hqsogb","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-07-20","time":"16:18:28","subject":"公告本公司調整配息率","clause":"第14款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-07-20 16:18，「公告本公司調整配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-07-20-1617-kh4r1o","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-07-20","time":"16:17:18","subject":"修正本公司114年度股東會年報部分內容","clause":"第44款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-07-20 16:17，「修正本公司114年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-07-20-1508-iywrok","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-07-20","time":"15:08:28","subject":"公告本公司115年股東常會補選董事一席","clause":"第6款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-07-20 15:08，「公告本公司115年股東常會補選董事一席」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-07-20-1011-ns9w1v","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-07-20","time":"10:11:37","subject":"本公司與DJT Medical Limited簽署香港及澳門地區獨家經銷協議","clause":"第8款","fact_date":"2026-07-20","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-07-20 10:11，「本公司與DJT Medical Limited簽署香港及澳門地區獨家經銷協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}